X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-13 | RCUS | Azoy Alexander | Chief Accounting Officer | S - Sale | $14.97 | -1,357 | 19,070 | -7% | -$20,314 | ||||||
2024-03-27 | RCUS | Jarrett Jennifer | COO | S - Sale | $17.55 | -11,551 | 215,253 | -5% | -$202,720 | ||||||
2024-03-18 | RCUS | Jarrett Jennifer | COO | S - Sale | $17.92 | -13,449 | 226,804 | -6% | -$240,941 | ||||||
| M | 2024-02-26 | RCUS | Jarrett Jennifer | COO | S - Sale | $20.09 | -58,625 | 240,253 | -20% | -$1,177,967 | |||||
| M | 2024-02-26 | RCUS | Jaen Juan C. | Pres | S - Sale | $20.09 | -27,032 | 1,529,708 | -2% | -$543,187 | |||||
2024-01-29 | RCUS | Gilead Sciences, Inc. | 10% | P - Purchase | $21.00 | +15,238,095 | 30,061,124 | +103% | +$319,999,995 | ||||||
2024-01-02 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $20.00 | -2,004 | 51,831 | -4% | -$40,080 | ||||||
2024-01-02 | RCUS | Jaen Juan C. | Pres | S - Sale | $20.09 | -6,975 | 1,516,740 | 0% | -$140,128 | ||||||
2023-12-22 | RCUS | Jarrett Jennifer | COO | S - Sale | $17.76 | -21,521 | 258,878 | -8% | -$382,213 | ||||||
2023-12-01 | RCUS | Azoy Alexander | Chief Accounting Officer | S - Sale | $14.95 | -282 | 11,596 | -2% | -$4,216 | ||||||
2023-09-22 | RCUS | Jarrett Jennifer | COO | S - Sale | $19.99 | -21,369 | 302,691 | -7% | -$427,166 | ||||||
2023-07-28 | RCUS | Jarrett Jennifer | COO | S - Sale | $20.25 | -45,000 | 336,566 | -12% | -$911,250 | ||||||
2023-07-03 | RCUS | Azoy Alexander | Chief Accounting Officer | S - Sale | $20.41 | -1,018 | 11,596 | -8% | -$20,777 | ||||||
2023-06-28 | RCUS | Gilead Sciences, Inc. | 10% | P - Purchase | $19.26 | +1,010,000 | 14,823,029 | +7% | +$19,452,600 | ||||||
2023-06-22 | RCUS | Jarrett Jennifer | COO | S - Sale | $19.12 | -12,437 | 381,566 | -3% | -$237,795 | ||||||
2023-06-16 | RCUS | Jarrett Jennifer | COO | S - Sale | $19.35 | -12,563 | 394,003 | -3% | -$243,094 | ||||||
2023-06-07 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $20.04 | -4,049 | 59,392 | -6% | -$81,142 | ||||||
2023-03-16 | RCUS | Jarrett Jennifer | COO | S - Sale | $16.81 | -8,729 | 406,217 | -2% | -$146,734 | ||||||
| M | 2023-01-26 | RCUS | Jarrett Jennifer | COO | S - Sale | $23.53 | -1,900 | 414,946 | 0% | -$44,700 | |||||
2022-12-16 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $30.75 | -2,453 | 11,566 | -17% | -$75,430 | ||||||
2022-12-16 | RCUS | Tang Carolyn C. | GC | S - Sale | $30.75 | -2,523 | 28,584 | -8% | -$77,582 | ||||||
2022-12-16 | RCUS | Jarrett Jennifer | COO | S - Sale | $30.75 | -16,482 | 147,609 | -10% | -$506,822 | ||||||
2022-12-16 | RCUS | Jaen Juan C. | Pres | S - Sale | $30.75 | -4,436 | 1,440,498 | 0% | -$136,407 | ||||||
2022-12-16 | RCUS | Rosen Terry J | CEO | S - Sale | $30.75 | -13,043 | 3,676,043 | 0% | -$401,073 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |